Lv1
18 积分 2025-08-28 加入
FXR agonists in NASH treatment
7个月前
已完结
Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism
7个月前
已完结
MicroRNA-206-3p suppresses hepatic lipogenesis and cholesterol synthesis while driving cholesterol efflux
8个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
8个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
8个月前
已完结
Metabolic dysfunction-associated steatotic liver disease in adults
8个月前
已完结
Human assembloids recapitulate periportal liver tissue in vitro
8个月前
已完结
Secondary Metabolism in Taxus spp. Plant Cell Culture In Vitro
8个月前
已完结
The development of peptide-drug conjugates (PDCs) strategies for paclitaxel
8个月前
已完结
Framework Nucleic Acid-programmed Aptamer–paclitaxel Conjugates as Targeted Therapeutics for Triple-negative Breast Cancer
8个月前
已完结
皖公网安备34019202002308
